Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Anticonvulsant effects In studies on rats with drug-induced epilepsy, DSIP acted as an anticonvulsant, significantly decreasing both the incidence and duration of seizures
GLP-1s may offer a dual benefit for patients with chronic conditions like diabetes or obesity who are also struggling with a substance use disorder: one medication can treat both conditions at once, Al-Aly said
[1] Important safety considerations include the risk of hypoglycaemia when combined with insulin or sulfonylureas, potential dehydration and acute kidney injury with severe gastrointestinal symptoms, and for semaglutide specifically, possible worsening of diabetic retinopathy in those with pre-existing disease
2018 Jul;24(7):931-938
US$ 28.82
US$ 21.11
US$ 21.72
US$ 28.68
US$ 27.37
US$ 28.61
US$ 22.32
